reference/12230773

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12230773

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1664-3224
pageRange	2053-
publicationName	Frontiers in Immunology
startingPage	2053
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b8e87d2df33bffbdb2cada4bc4ae61d5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ca90c33c4e6a010cc888dd597c3b04c1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_45a902941094c32834f5d0deead1b3c9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_97eda065fbdd5ec829a58d9fb3ae6338
bibliographicCitation	Thompson GE, Fussner LA, Hummel AM, Schroeder DR, Silva F, Snyder MR, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St. Clair EW, Stone JH, Specks U. Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis. Front. Immunol. 2020 Sep 03;11(). doi: 10.3389/fimmu.2020.02053.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67dab568cc27722b207bb8ddbcc721fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b1f1c8b52cdb021a067ea8820d522a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bfed86e8096ff62d82428b92e0c87cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d6bcec0cdb3c553a4f6fcc9f98fd129 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88e9c126e624f71d109027b7e94c4c9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98aea13395ce43d1d506f7112fdf9b9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5746cdcc3f2b281f73291f1c1c4e9db2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5c008d1f2c2ce5213b8221cab7f2de6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51a2b55a202281f4cf8fad4e231dab5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b04382cf722ed1cdf82e728ce680db8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11a6ff34f7612036042d76e89c7331a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f93e3b49396e016d202ec83666a493fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eef40772cc44a62d9cb001557470971f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3846e2b5a6614d7cfc4fd155e7dd718
date	2020-09-03^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7495134 https://doi.org/10.3389/fimmu.2020.02053 https://pubmed.ncbi.nlm.nih.gov/33013868
isPartOf	https://portal.issn.org/resource/ISSN/1664-3224 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39309
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
discusses	http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0028696 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0161951 http://id.nlm.nih.gov/mesh/M0005485
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D012698Q000379 http://id.nlm.nih.gov/mesh/D019268Q000097 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D056648Q000175 http://id.nlm.nih.gov/mesh/D053146Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007118 http://id.nlm.nih.gov/mesh/D003520Q000627 http://id.nlm.nih.gov/mesh/D000069283Q000627 http://id.nlm.nih.gov/mesh/D056648Q000188 http://id.nlm.nih.gov/mesh/D007166Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11173 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_08107456d8bcd45da877127a55a55980

Showing number of triples: 1 to 57 of 57.